United Therapeutics Corporation logo

United Therapeutics Corporation (UTHR)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
535. 67
+6.62
+1.2513%
$
22.35B Market Cap
11.96 P/E Ratio
- Div Yield
422,200 Volume
24.04 Eps
$ 529.05
Previous Close
Add Transaction
Day Range
528.39 543.56
Year Range
272.12 609.35
Want to track UTHR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
United Therapeutics Corporation (UTHR) Q4 2025 Earnings Call Transcript

United Therapeutics Corporation (UTHR) Q4 2025 Earnings Call Transcript

United Therapeutics Corporation (UTHR) Q4 2025 Earnings Call Transcript

Seekingalpha | 4 months ago
Unveiling United Therapeutics (UTHR) Q4 Outlook: Wall Street Estimates for Key Metrics

Unveiling United Therapeutics (UTHR) Q4 Outlook: Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of United Therapeutics (UTHR) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks | 4 months ago
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term

Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 6 months ago
Here's Why United Therapeutics (UTHR) is a Strong Value Stock

Here's Why United Therapeutics (UTHR) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 6 months ago
United Therapeutics Corporation (UTHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

United Therapeutics Corporation (UTHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

United Therapeutics Corporation (UTHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seekingalpha | 6 months ago
UTHR or MDGL: Which Is the Better Value Stock Right Now?

UTHR or MDGL: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Drugs sector have probably already heard of United Therapeutics (UTHR) and Madrigal (MDGL). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks | 6 months ago
UTHR vs. ZTS: Which Stock Is the Better Value Option?

UTHR vs. ZTS: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Drugs sector might want to consider either United Therapeutics (UTHR) or Zoetis (ZTS). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 6 months ago
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock

Here's Why United Therapeutics (UTHR) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 6 months ago
Here's Why United Therapeutics (UTHR) is a Strong Value Stock

Here's Why United Therapeutics (UTHR) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 6 months ago
Here's Why United Therapeutics (UTHR) is a Strong Momentum Stock

Here's Why United Therapeutics (UTHR) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 7 months ago
Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term

Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 7 months ago
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term

Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 7 months ago
Loading...
Load More